[{"NetIncomeLoss_1_Q3_USD":45782000.0,"LongTermDebtCurrent_0_Q3_USD":12500000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":1820000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":1612000.0,"AssetsCurrent_0_Q3_USD":566606000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":11202000.0,"DividendsCommonStockCash_1_Q3_USD":12446000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q3_USD":10302000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-1142000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour_0_Q3_USD":51959000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":27700000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":700000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-16613000.0,"IncomeTaxesPaid_3_Q3_USD":17957000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":35400000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-64023000.0,"InterestPaidNet_3_Q3_USD":10729000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":15689000.0,"CommonStockDividendsPerShareDeclared_1_Q3_USD":0.32,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q3_USD":-1801000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":238310000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":82596000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_3_Q3_USD":5490000.0,"IncreaseDecreaseInAccountsAndOtherReceivables_3_Q3_USD":32710000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":57.5,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"OperatingLeaseRightOfUseAsset_0_Q3_USD":71830000.0,"ShareBasedCompensation_3_Q3_USD":39174000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":146000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":33190000.0,"Assets_0_Q3_USD":2084642000.0,"CommonStockSharesIssued_0_Q3_shares":38854000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":12138000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":16994000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":1800000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":1600000.0,"PaymentsToAcquireAvailableForSaleSecurities_3_Q3_USD":39684000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":75278000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":215098000.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":0.0,"ContractWithCustomerLiability_0_Q3_USD":19700000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_1_Q3_USD":1288000.0,"CommonStockDividendsPerShareDeclared_3_Q3_USD":0.96,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":15511000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":-509000.0,"OperatingLeaseLiability_0_Q3_USD":77230000.0,"RepaymentsOfLinesOfCredit_3_Q3_USD":141375000.0,"InvestmentIncomeNet_1_Q3_USD":114000.0,"InvestmentIncomeNet_3_Q3_USD":306000.0,"CommonStockValue_0_Q3_USD":389000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths_0_Q3_USD":59539000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-48000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":16121000.0,"AccountsReceivableNetCurrent_0_Q3_USD":157790000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":12198000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-20726000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":40676000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":40305000.0,"MinorityInterest_0_Q3_USD":8489000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":66377000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_1_Q3_USD":-69000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_3_Q3_USD":14000.0,"EarningsPerShareBasic_1_Q3_USD":1.18,"EarningsPerShareBasic_3_Q3_USD":3.24,"OtherNonoperatingIncomeExpense_3_Q3_USD":-17297000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo_0_Q3_USD":57647000.0,"IncreaseDecreaseInOtherCurrentAssets_3_Q3_USD":-414000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":63075000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":514299000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":66816000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":186136000.0,"OtherAssetsNoncurrent_0_Q3_USD":11593000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":46237000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":45997000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":158626000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":45755000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":125373000.0,"IncreaseDecreaseInInventories_3_Q3_USD":4115000.0,"OtherAssetsCurrent_0_Q3_USD":22582000.0,"AvailableForSaleSecuritiesCurrent_0_Q3_USD":90108000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":-155000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-180239000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":17052000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":49882000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":13829000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":-0.001,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.114,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":-380000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":10278000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_3_Q3_USD":9765000.0,"CommonStockSharesAuthorized_0_Q3_shares":100000000.0,"InterestExpense_1_Q3_USD":2660000.0,"InterestExpense_3_Q3_USD":10661000.0,"NonoperatingIncomeExpense_1_Q3_USD":-23272000.0,"NonoperatingIncomeExpense_3_Q3_USD":-27652000.0,"AccountsPayableCurrent_0_Q3_USD":25842000.0,"LiabilitiesCurrent_0_Q3_USD":137640000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":13081000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q3_USD":5070000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_Q3_USD":6219000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":38856000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":51664000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":230144000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":10232000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":45354000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":141062000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q3_USD":202931000.0,"Goodwill_0_Q3_USD":746460000.0,"ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_1_Q3_USD":11700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":38693000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":54992000.0,"DeferredIncomeTaxesAndTaxCredits_3_Q3_USD":-6023000.0,"AccruedIncomeTaxesCurrent_0_Q3_USD":3562000.0,"NetIncomeLoss_3_Q3_USD":125450000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":198975000.0,"ProceedsFromPaymentsForOtherFinancingActivities_3_Q3_USD":-13504000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":7100000.0,"BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_0_Q3_USD":10800000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":98401000.0,"OperatingLeasePayments_3_Q3_USD":9898000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":489178000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":1328000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":505137.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":1547942000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":186136000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":45755000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":125373000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.0415,"PaymentsOfDividendsCommonStock_3_Q3_USD":37174000.0,"GrossProfit_1_Q3_USD":168274000.0,"GrossProfit_3_Q3_USD":456906000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":489178000.0,"ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_3_Q3_USD":19700000.0,"OtherOperatingActivitiesCashFlowStatement_3_Q3_USD":-608000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":215000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":33176000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":7793000.0,"OperatingExpenses_1_Q3_USD":99648000.0,"OperatingExpenses_3_Q3_USD":288192000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":15060000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":10414000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":385894000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":43268000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":2084642000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":269.64,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":18714000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":108000000.0,"StockRepurchasedDuringPeriodValue_1_Q3_USD":43178000.0,"InventoryNet_0_Q3_USD":109990000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_3_Q3_USD":3528000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":43178000.0,"OperatingIncomeLoss_1_Q3_USD":68626000.0,"OperatingIncomeLoss_3_Q3_USD":168714000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":243552000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":672004000.0,"FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_3_Q3_USD":-4203000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":92741000.0,"ProfitLoss_3_Q3_USD":124941000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":23812000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":186919000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q3_USD":1600000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":9700000.0,"EarningsPerShareDiluted_1_Q3_USD":1.12,"EarningsPerShareDiluted_3_Q3_USD":3.11,"CommonStockSharesOutstanding_0_Q3_shares":38854000.0,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_1_Q3_USD":27000.0,"UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_3_Q3_USD":77000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":39511000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":1088788000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree_0_Q3_USD":55016000.0,"VariableLeaseCost_3_Q3_USD":2400000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_1_Q3_USD":411000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":1428000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":32985000.0,"StockholdersEquity_0_Q3_USD":1539453000.0,"GoodwillAcquiredDuringPeriod_1_Q3_USD":7848000.0,"OtherLiabilitiesCurrent_0_Q3_USD":2581000.0,"FinitelivedIntangibleAssetsAcquired1_3_Q3_USD":8917000.0,"ProfitLoss_1_Q3_USD":45402000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":4498000.0,"Ticker":"TECH","CIK":"842023","name":"BIO-TECHNE CORP","OfficialName":"Bio-Techne Corp Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"16235870966.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"SP500","filed":"20210507"}]